Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.

Revenue
+4.59%
EPS
+128.9%
Free cash flow
−9.03%
Total debt
−4.51%

Quarter to September 2026, against a year earlier

15.14 0.51 −3.26%
Market cap
$10.3B
P/E
30.3×
Fwd P/E
34.8×
Dividend yield
—
F-score
4/9
Altman Z
1.55
Beneish M
−2.91
Dividend safety
n/a

Avantor, Inc. (AVTR) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Avantor, Inc. (AVTR) trades at a EV/Sales of 2.0×. Over the past ten years it has ranged from 0.0× (June 2019) to 4.4× (September 2021); the current reading is higher than 25% of that period. That is below the Medical Instruments & Supplies industry median of 2.8× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.7× (34.95%)
FY2024 2.7× (9.89%)
FY2023 3.0× 13.02%
FY2022 2.6× (38.73%)
FY2021 4.3× 31.34%
FY2020 3.3× 61.15%
FY2019 2.0× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period EV/Sales Change
Sep 2026 2.0× 31.47%
Jun 2026 1.5× 14.00%
Mar 2026 1.3× (22.37%)
Dec 2025 1.7× (5.72%)
29 more quarters

Against its own ten years

Low 0.0× High 4.4×
Ten-year median 2.7×
Current reading's percentile 24

EV/Sales against peers

Company EV/Sales
BAX Baxter International Inc. compare 1.7×
AVTR Avantor, Inc. 2.0×
BLCO Bausch + Lomb Corporation compare 2.2×
SOLV Solventum Corporation compare 2.4×
ALGN Align Technology, Inc. compare 2.4×
ATR AptarGroup, Inc. compare 2.6×
COO The Cooper Companies, Inc. compare 3.5×
TFX Teleflex Incorporated compare 4.1×
RGEN Repligen Corporation compare 11.6×
Medical Instruments & Supplies industry median 2.8×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on AVTR